Compare Gemini Space Station Inc (GEMI) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Zoetis Inc — how do they compare? Gemini Space Station Inc trades at $4.18 (market cap $512.05M), while Zoetis Inc trades at $73.7 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 60.8× Gemini Space Station Inc's market cap, and Zoetis Inc pays a 2.81% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals.
| GEMI | ZTS | |
|---|---|---|
Market Cap | $512.05M | $31.14B |
Sector | Technology | Health |
52-Week High | $32.52 | $156.76 |
52-Week Low | $3.90 | $71.91 |
Enterprise Value | $502.04M | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.17, up 1.46% on the day, amid bearish technical signals and deeply negative profitability. The stock faces headwinds from consecutive quarterly earnings misses, with Q2 2026 results due August 13, 2026. Recent news highlights a $100 million investment from Winklevoss Capital but also multiple class-action lawsuits alleging securities law violations, creating a mixed sentiment environment.
The outlook remains challenging due to persistent losses and high cash burn, though analyst consensus suggests moderate upside to a $6.33 price target. Key risks include ongoing legal pressures, competitive threats in fintech, and the company's ability to achieve profitability. Investors should weigh the speculative growth potential against substantial fundamental weaknesses.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
